Smoking Cessation and Nicotine De-Addiction Market – Scope of Report

TMR’s report on the global Smoking Cessation and Nicotine De-Addiction Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Smoking Cessation and Nicotine De-Addiction Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Smoking Cessation and Nicotine De-Addiction Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Global Smoking Cessation and Nicotine De-Addiction Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Global Smoking Cessation and Nicotine De-Addiction Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Global Smoking Cessation and Nicotine De-Addiction Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the Global Smoking Cessation and Nicotine De-Addiction Market .

The report delves into the competitive landscape of the Global Smoking Cessation and Nicotine De-Addiction Market. Key players operating in the global Smoking Cessation and Nicotine De-Addiction Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Smoking Cessation and Nicotine De-Addiction Market profiled in this report.

Key Questions Answered in Global Smoking Cessation and Nicotine De-Addiction Market Report

• What is the sales/revenue generated by Smoking Cessation and Nicotine De-Addiction Market across all regions during the forecast period?
• What are the opportunities in the global Smoking Cessation and Nicotine De-Addiction Market?
• What are the major drivers, restraints, opportunities, and threats in the Market?
• Which regional Market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the Market positions of different companies operating in the global Market?

Global Smoking Cessation and Nicotine De-Addiction Market – Research Objectives and Research Approach

The comprehensive report on the global Smoking Cessation and Nicotine De-Addiction Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Smoking Cessation and Nicotine De-Addiction Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market Share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the Smoking Cessation and Nicotine De-Addiction Market.

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Geographical Coverage
1.4. Market Taxonomy
2. Executive Summary
3. Market Overview
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunities
3.2. Key Trends Analysis
3.2.1. Demand Side Analysis
3.2.2. Supply Side Analysis
3.3. Key Market Indicators
3.4. Porter’s Five Forces Analysis
3.5. PESTEL Analysis
3.6. Value Chain Analysis
3.6.1. List of Manufacturers
3.6.2. List of Raw Material Suppliers
3.6.3. List of Potential Customers
3.6.4. List of Distributors/Suppliers
4. Premium Insights
4.1. Key Forecast Factors & Impact
4.2. Opportunity Assessment
4.3. Technological Integration
4.3.1. Advanced Nicotine Delivery Systems Innovation
4.3.2. Digital Therapeutics and AI-Driven Behavioral Support Platforms
4.3.3. Sustainable and High-Barrier Packaging Material Advancements
4.3.4. Combination Therapy and Personalized Dosage Technologies
4.4. Standard and Regulations
4.4.1. OTC versus Prescription Classification Frameworks
4.4.2. Nicotine Content Standardization and Labeling Compliance Mandates
4.4.3. Child-Resistant and Tamper-Evident Packaging Regulations
4.4.4. Advertising, Promotion, and Marketing Restriction Policies
4.5. Price Benchmarking by Product Type
4.6. Clinical Efficacy & Comparative Effectiveness
4.7. Effective Marketing & Branding Strategies
5. Pricing Analysis, 2025
5.1. Weighted Average Selling Price, by Region
5.2. Factors Impacting Price
6. Voice of Consumers
7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
7.1. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
7.1.1. Nicotine-Based (NRT)
7.1.1.1. Transdermal Patches
7.1.1.2. Gum
7.1.1.3. Lozenges/Tablets
7.1.1.4. Inhalers
7.1.1.5. Others (Nasal Sprays, etc.)
7.1.2. Non-Nicotine Prescription Drugs
7.1.2.1. Varenicline Class
7.1.2.2. Bupropion Class
7.1.2.3. Other approved prescription molecules
7.2. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
7.2.1. Men
7.2.2. Women
7.3. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
7.3.1. Online
7.3.1.1. Company-owned Websites
7.3.1.2. E-commerce Websites
7.3.2. Offline
7.3.2.1. Supermarkets/Hypermarkets
7.3.2.2. Drug Stores
7.3.2.3. Departmental Stores
7.3.2.4. Others (Gas Stations, etc.)
7.4. Market Size and Forecast (US$ Bn & Thousand Units) by Region, 2021-2036
7.4.1. North America
7.4.1.1. U.S.
7.4.1.2. Canada
7.4.2. Europe
7.4.2.1. U.K.
7.4.2.2. Germany
7.4.2.3. France
7.4.2.4. Italy
7.4.2.5. Spain
7.4.2.6. The Netherlands
7.4.2.7. Rest of Europe
7.4.3. Asia Pacific
7.4.3.1. China
7.4.3.2. India
7.4.3.3. Japan
7.4.3.4. Australia
7.4.3.5. South Korea
7.4.3.6. ASEAN
7.4.3.7. Rest of Asia Pacific
7.4.4. Middle East & Africa
7.4.4.1. GCC Countries
7.4.4.2. South Africa
7.4.4.3. Rest of Middle East & Africa
7.4.5. Latin America
7.4.5.1. Brazil
7.4.5.2. Mexico
7.4.5.3. Argentina
7.4.5.4. Rest of Latin America
7.5. Incremental Opportunity Analysis
8. North America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
8.1. Regional Snapshot
8.2. Demographic Scenario
8.3. Market Share Analysis
8.4. Key Trend Analysis
8.5. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
8.5.1. Nicotine-Based (NRT)
8.5.1.1. Transdermal Patches
8.5.1.2. Gum
8.5.1.3. Lozenges/Tablets
8.5.1.4. Inhalers
8.5.1.5. Others (Nasal Sprays, etc.)
8.5.2. Non-Nicotine Prescription Drugs
8.5.2.1. Varenicline Class
8.5.2.2. Bupropion Class
8.5.2.3. Other approved prescription molecules
8.6. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
8.6.1. Men
8.6.2. Women
8.7. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
8.7.1. Online
8.7.1.1. Company-owned Websites
8.7.1.2. E-commerce Websites
8.7.2. Offline
8.7.2.1. Supermarkets/Hypermarkets
8.7.2.2. Drug Stores
8.7.2.3. Departmental Stores
8.7.2.4. Others (Gas Stations, etc.)
8.8. Market Size and Forecast (US$ Bn & Thousand Units) by Country, 2021-2036
8.8.1. U.S.
8.8.2. Canada
8.9. Incremental Opportunity Analysis
9. U.S. Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
9.1. Country Snapshot
9.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
9.2.1. Nicotine-Based (NRT)
9.2.1.1. Transdermal Patches
9.2.1.2. Gum
9.2.1.3. Lozenges/Tablets
9.2.1.4. Inhalers
9.2.1.5. Others (Nasal Sprays, etc.)
9.2.2. Non-Nicotine Prescription Drugs
9.2.2.1. Varenicline Class
9.2.2.2. Bupropion Class
9.2.2.3. Other approved prescription molecules
9.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
9.3.1. Men
9.3.2. Women
9.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
9.4.1. Online
9.4.1.1. Company-owned Websites
9.4.1.2. E-commerce Websites
9.4.2. Offline
9.4.2.1. Supermarkets/Hypermarkets
9.4.2.2. Drug Stores
9.4.2.3. Departmental Stores
9.4.2.4. Others (Gas Stations, etc.)
9.5. Incremental Opportunity Analysis
10. Canada Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
10.1. Country Snapshot
10.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
10.2.1. Nicotine-Based (NRT)
10.2.1.1. Transdermal Patches
10.2.1.2. Gum
10.2.1.3. Lozenges/Tablets
10.2.1.4. Inhalers
10.2.1.5. Others (Nasal Sprays, etc.)
10.2.2. Non-Nicotine Prescription Drugs
10.2.2.1. Varenicline Class
10.2.2.2. Bupropion Class
10.2.2.3. Other approved prescription molecules
10.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
10.3.1. Men
10.3.2. Women
10.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
10.4.1. Online
10.4.1.1. Company-owned Websites
10.4.1.2. E-commerce Websites
10.4.2. Offline
10.4.2.1. Supermarkets/Hypermarkets
10.4.2.2. Drug Stores
10.4.2.3. Departmental Stores
10.4.2.4. Others (Gas Stations, etc.)
10.5. Incremental Opportunity Analysis
11. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
11.1. Regional Snapshot
11.2. Demographic Scenario
11.3. Market Share Analysis
11.4. Key Trend Analysis
11.5. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
11.5.1. Nicotine-Based (NRT)
11.5.1.1. Transdermal Patches
11.5.1.2. Gum
11.5.1.3. Lozenges/Tablets
11.5.1.4. Inhalers
11.5.1.5. Others (Nasal Sprays, etc.)
11.5.2. Non-Nicotine Prescription Drugs
11.5.2.1. Varenicline Class
11.5.2.2. Bupropion Class
11.5.2.3. Other approved prescription molecules
11.6. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
11.6.1. Men
11.6.2. Women
11.7. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
11.7.1. Online
11.7.1.1. Company-owned Websites
11.7.1.2. E-commerce Websites
11.7.2. Offline
11.7.2.1. Supermarkets/Hypermarkets
11.7.2.2. Drug Stores
11.7.2.3. Departmental Stores
11.7.2.4. Others (Gas Stations, etc.)
11.8. Market Size and Forecast (US$ Bn & Thousand Units) by Country, 2021-2036
11.8.1. U.K.
11.8.2. Germany
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. The Netherlands
11.8.7. Rest of Europe
11.9. Incremental Opportunity Analysis
12. U.K. Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
12.1. Country Snapshot
12.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
12.2.1. Nicotine-Based (NRT)
12.2.1.1. Transdermal Patches
12.2.1.2. Gum
12.2.1.3. Lozenges/Tablets
12.2.1.4. Inhalers
12.2.1.5. Others (Nasal Sprays, etc.)
12.2.2. Non-Nicotine Prescription Drugs
12.2.2.1. Varenicline Class
12.2.2.2. Bupropion Class
12.2.2.3. Other approved prescription molecules
12.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
12.3.1. Men
12.3.2. Women
12.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
12.4.1. Online
12.4.1.1. Company-owned Websites
12.4.1.2. E-commerce Websites
12.4.2. Offline
12.4.2.1. Supermarkets/Hypermarkets
12.4.2.2. Drug Stores
12.4.2.3. Departmental Stores
12.4.2.4. Others (Gas Stations, etc.)
12.5. Incremental Opportunity Analysis
13. Germany Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
13.1. Country Snapshot
13.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
13.2.1. Nicotine-Based (NRT)
13.2.1.1. Transdermal Patches
13.2.1.2. Gum
13.2.1.3. Lozenges/Tablets
13.2.1.4. Inhalers
13.2.1.5. Others (Nasal Sprays, etc.)
13.2.2. Non-Nicotine Prescription Drugs
13.2.2.1. Varenicline Class
13.2.2.2. Bupropion Class
13.2.2.3. Other approved prescription molecules
13.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
13.3.1. Men
13.3.2. Women
13.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
13.4.1. Online
13.4.1.1. Company-owned Websites
13.4.1.2. E-commerce Websites
13.4.2. Offline
13.4.2.1. Supermarkets/Hypermarkets
13.4.2.2. Drug Stores
13.4.2.3. Departmental Stores
13.4.2.4. Others (Gas Stations, etc.)
13.5. Incremental Opportunity Analysis
14. France Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
14.1. Country Snapshot
14.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
14.2.1. Nicotine-Based (NRT)
14.2.1.1. Transdermal Patches
14.2.1.2. Gum
14.2.1.3. Lozenges/Tablets
14.2.1.4. Inhalers
14.2.1.5. Others (Nasal Sprays, etc.)
14.2.2. Non-Nicotine Prescription Drugs
14.2.2.1. Varenicline Class
14.2.2.2. Bupropion Class
14.2.2.3. Other approved prescription molecules
14.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
14.3.1. Men
14.3.2. Women
14.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
14.4.1. Online
14.4.1.1. Company-owned Websites
14.4.1.2. E-commerce Websites
14.4.2. Offline
14.4.2.1. Supermarkets/Hypermarkets
14.4.2.2. Drug Stores
14.4.2.3. Departmental Stores
14.4.2.4. Others (Gas Stations, etc.)
14.5. Incremental Opportunity Analysis
15. Italy Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
15.1. Country Snapshot
15.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
15.2.1. Nicotine-Based (NRT)
15.2.1.1. Transdermal Patches
15.2.1.2. Gum
15.2.1.3. Lozenges/Tablets
15.2.1.4. Inhalers
15.2.1.5. Others (Nasal Sprays, etc.)
15.2.2. Non-Nicotine Prescription Drugs
15.2.2.1. Varenicline Class
15.2.2.2. Bupropion Class
15.2.2.3. Other approved prescription molecules
15.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
15.3.1. Men
15.3.2. Women
15.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
15.4.1. Online
15.4.1.1. Company-owned Websites
15.4.1.2. E-commerce Websites
15.4.2. Offline
15.4.2.1. Supermarkets/Hypermarkets
15.4.2.2. Drug Stores
15.4.2.3. Departmental Stores
15.4.2.4. Others (Gas Stations, etc.)
15.5. Incremental Opportunity Analysis
16. Spain Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
16.1. Country Snapshot
16.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
16.2.1. Nicotine-Based (NRT)
16.2.1.1. Transdermal Patches
16.2.1.2. Gum
16.2.1.3. Lozenges/Tablets
16.2.1.4. Inhalers
16.2.1.5. Others (Nasal Sprays, etc.)
16.2.2. Non-Nicotine Prescription Drugs
16.2.2.1. Varenicline Class
16.2.2.2. Bupropion Class
16.2.2.3. Other approved prescription molecules
16.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
16.3.1. Men
16.3.2. Women
16.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
16.4.1. Online
16.4.1.1. Company-owned Websites
16.4.1.2. E-commerce Websites
16.4.2. Offline
16.4.2.1. Supermarkets/Hypermarkets
16.4.2.2. Drug Stores
16.4.2.3. Departmental Stores
16.4.2.4. Others (Gas Stations, etc.)
16.5. Incremental Opportunity Analysis
17. The Netherlands Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
17.1. Country Snapshot
17.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
17.2.1. Nicotine-Based (NRT)
17.2.1.1. Transdermal Patches
17.2.1.2. Gum
17.2.1.3. Lozenges/Tablets
17.2.1.4. Inhalers
17.2.1.5. Others (Nasal Sprays, etc.)
17.2.2. Non-Nicotine Prescription Drugs
17.2.2.1. Varenicline Class
17.2.2.2. Bupropion Class
17.2.2.3. Other approved prescription molecules
17.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
17.3.1. Men
17.3.2. Women
17.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
17.4.1. Online
17.4.1.1. Company-owned Websites
17.4.1.2. E-commerce Websites
17.4.2. Offline
17.4.2.1. Supermarkets/Hypermarkets
17.4.2.2. Drug Stores
17.4.2.3. Departmental Stores
17.4.2.4. Others (Gas Stations, etc.)
17.5. Incremental Opportunity Analysis
18. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
18.1. Regional Snapshot
18.2. Demographic Scenario
18.3. Market Share Analysis
18.4. Key Trend Analysis
18.5. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
18.5.1. Nicotine-Based (NRT)
18.5.1.1. Transdermal Patches
18.5.1.2. Gum
18.5.1.3. Lozenges/Tablets
18.5.1.4. Inhalers
18.5.1.5. Others (Nasal Sprays, etc.)
18.5.2. Non-Nicotine Prescription Drugs
18.5.2.1. Varenicline Class
18.5.2.2. Bupropion Class
18.5.2.3. Other approved prescription molecules
18.6. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
18.6.1. Men
18.6.2. Women
18.7. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
18.7.1. Online
18.7.1.1. Company-owned Websites
18.7.1.2. E-commerce Websites
18.7.2. Offline
18.7.2.1. Supermarkets/Hypermarkets
18.7.2.2. Drug Stores
18.7.2.3. Departmental Stores
18.7.2.4. Others (Gas Stations, etc.)
18.8. Market Size and Forecast (US$ Bn & Thousand Units) by Country, 2021-2036
18.8.1. China
18.8.2. India
18.8.3. Japan
18.8.4. Australia
18.8.5. South Korea
18.8.6. ASEAN
18.8.7. Rest of Asia Pacific
18.9. Incremental Opportunity Analysis
19. China Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
19.1. Country Snapshot
19.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
19.2.1. Nicotine-Based (NRT)
19.2.1.1. Transdermal Patches
19.2.1.2. Gum
19.2.1.3. Lozenges/Tablets
19.2.1.4. Inhalers
19.2.1.5. Others (Nasal Sprays, etc.)
19.2.2. Non-Nicotine Prescription Drugs
19.2.2.1. Varenicline Class
19.2.2.2. Bupropion Class
19.2.2.3. Other approved prescription molecules
19.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
19.3.1. Men
19.3.2. Women
19.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
19.4.1. Online
19.4.1.1. Company-owned Websites
19.4.1.2. E-commerce Websites
19.4.2. Offline
19.4.2.1. Supermarkets/Hypermarkets
19.4.2.2. Drug Stores
19.4.2.3. Departmental Stores
19.4.2.4. Others (Gas Stations, etc.)
19.5. Incremental Opportunity Analysis
20. India Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
20.1. Country Snapshot
20.2. Market Size and Forecast (US$ Bn & Thousand Units) by Product Type, 2021-2036
20.2.1. Nicotine-Based (NRT)
20.2.1.1. Transdermal Patches
20.2.1.2. Gum
20.2.1.3. Lozenges/Tablets
20.2.1.4. Inhalers
20.2.1.5. Others (Nasal Sprays, etc.)
20.2.2. Non-Nicotine Prescription Drugs
20.2.2.1. Varenicline Class
20.2.2.2. Bupropion Class
20.2.2.3. Other approved prescription molecules
20.3. Market Size and Forecast (US$ Bn & Thousand Units) by Consumer Group, 2021-2036
20.3.1. Men
20.3.2. Women
20.4. Market Size and Forecast (US$ Bn & Thousand Units) by Distribution Channel, 2021-2036
20.4.1. Online
20.4.1.1. Company-owned Websites
20.4.1.2. E-commerce Websites
20.4.2. Offline
20.4.2.1. Supermarkets/Hypermarkets
20.4.2.2. Drug Stores
20.4.2.3. Departmental Stores
20.4.2.4. Others (Gas Stations, etc.)
20.5. Incremental Opportunity Analysis